According to a market report by Lucintel, the future of the global pharmaceutical contract manufacturing market looks promising with opportunities in the big pharmaceutical, small & medium-sized pharmaceutical, and generic pharmaceutical markets. The global pharmaceutical contract manufacturing market is expected to reach an estimated $396 billion by 2035 with a CAGR of 6.9% from 2026 to 2035. The major drivers for this market are the growing demand for faster drug production & delivery, the rising need for advanced manufacturing technologies, and the increasing outsourcing by pharmaceutical companies to reduce costs.
A more
than 150-page report to understand trends, opportunity and forecast in global pharmaceutical
contract manufacturing market to 2035 by services (manufacturing, drug
development, and biologics manufacturing), end use (big pharmaceutical, small
& medium-sized pharmaceutical, generic pharmaceutical, and others), and
region (North America, Europe, Asia Pacific, and the Rest of the World).
Lucintel
forecasts that, within the Services category, biologic manufacturing is
expected to witness the highest growth over the forecast period due to the
increasing demand for biologics production outsourcing.
Within the
end use category, big pharmaceutical is expected to witness the highest growth
due to the rising drug development pipelines and biologics investments.
Download
sample by clicking on pharmaceutical
contract manufacturing market.
In terms
of regions, APAC is expected to witness the highest growth over the forecast
period due to the rapid pharmaceutical manufacturing expansion and cost
advantages.
Thermo
Fisher Scientific, Catalent, Lonza, Almac Group, Recipharm, Patheon, Grifols
International are the major suppliers in the pharmaceutical contract manufacturing market.
This unique research
report will enable you to make confident business decisions in this globally
competitive marketplace. For a detailed table of contents, contact Lucintel at
+1-972-636-5056 or write us at helpdesk@lucintel.com. To get access of more than 1000 reports at fraction of cost
visit Lucintel's Analytics
Dashboard.
About Lucintel
At Lucintel, we offer solutions for
you growth through game changer ideas and robust market &
unmet needs analysis. We are based in
Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20
years. We are quoted in several publications like the Wall Street Journal,
ZACKS, and the Financial Times.
Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: roy.almaguer@lucintel.com
Tel. +1-972-636-5056
Explore Our Latest Publications
Semiconductor Molding System Market
Semiconductor Plating Chemical Market
No comments:
Post a Comment